Kimia Biosciences Ltd Holds 33rd AGM on Sep 28, 2026

Kimia Biosciences Limited has announced its 33rd Annual General Meeting (AGM) scheduled for Monday, September 28, 2026, at 03:00 P.M. (IST) via Video Conferencing/Other Audio-Visual Means. The company will transact businesses as outlined in the AGM notice. The Annual Report for the financial year 2025-26, along with the AGM notice, is being sent electronically to shareholders and will be available on the company's website, BSE, and NSDL e-Voting platform. The report highlights the company's R&D objectives, including investments in drug research and development to address unmet patient needs. A significant achievement mentioned is the grant of a patent in January 2026 for Luliconazole, an antifungal drug.